PF-Atlas › Clinical Trials › NCT05313087
COVID-19 Vaccine Response in Chronic Respiratory Conditions
COVID-19 vaccine · Not specified
Registry ID
NCT05313087
Phase
Not specified
Status
Completed
Drug / intervention
COVID-19 vaccine
Sponsor
National Jewish Health
Start
2021-02-03
About this trial
COVID-19 vaccine is evaluated in NCT05313087, a idiopathic pulmonary fibrosis study sponsored by National Jewish Health. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05313087 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.